AIRLINK 72.90 Decreased By ▼ -2.26 (-3.01%)
BOP 5.40 Decreased By ▼ -0.05 (-0.92%)
CNERGY 4.33 Decreased By ▼ -0.06 (-1.37%)
DFML 28.40 Increased By ▲ 0.76 (2.75%)
DGKC 73.65 Increased By ▲ 1.65 (2.29%)
FCCL 20.36 Increased By ▲ 0.07 (0.34%)
FFBL 30.80 Decreased By ▼ -0.25 (-0.81%)
FFL 10.04 Increased By ▲ 0.07 (0.7%)
GGL 10.40 Increased By ▲ 0.13 (1.27%)
HBL 115.51 Increased By ▲ 0.51 (0.44%)
HUBC 131.51 Increased By ▲ 0.06 (0.05%)
HUMNL 6.77 Decreased By ▼ -0.10 (-1.46%)
KEL 4.06 Decreased By ▼ -0.14 (-3.33%)
KOSM 4.65 Decreased By ▼ -0.12 (-2.52%)
MLCF 38.40 Increased By ▲ 1.32 (3.56%)
OGDC 134.19 Decreased By ▼ -1.26 (-0.93%)
PAEL 23.90 Increased By ▲ 0.50 (2.14%)
PIAA 27.35 Increased By ▲ 0.04 (0.15%)
PIBTL 6.49 Decreased By ▼ -0.11 (-1.67%)
PPL 113.25 Increased By ▲ 0.09 (0.08%)
PRL 28.27 Decreased By ▼ -0.48 (-1.67%)
PTC 15.10 Decreased By ▼ -0.40 (-2.58%)
SEARL 56.56 Decreased By ▼ -0.77 (-1.34%)
SNGP 65.85 Decreased By ▼ -1.14 (-1.7%)
SSGC 11.00 Decreased By ▼ -0.17 (-1.52%)
TELE 9.03 Decreased By ▼ -0.11 (-1.2%)
TPLP 11.90 Decreased By ▼ -0.15 (-1.24%)
TRG 69.44 Decreased By ▼ -0.95 (-1.35%)
UNITY 23.60 Decreased By ▼ -0.05 (-0.21%)
WTL 1.33 Decreased By ▼ -0.01 (-0.75%)
BR100 7,435 Decreased By -20.3 (-0.27%)
BR30 24,208 Decreased By -41.6 (-0.17%)
KSE100 71,366 Decreased By -67.3 (-0.09%)
KSE30 23,561 Decreased By -5 (-0.02%)
World

Bangladesh to begin COVID-19 vaccinations next month

  • The South Asian country of more than 160 million in November signed a deal with the Serum Institute of India to buy 30 million doses of the vaccine developed by British drugmaker AstraZeneca.
  • The vaccine will be first applied on the health workers and it will be monitored for the next seven days. After that, we'll begin the vaccination across the country in the first week of February.
Published January 11, 2021

DHAKA: Bangladesh will begin inoculating people against COVID-19 in the first week of February as it hopes to get the vaccine by end of this month, a senior health ministry official said on Monday.

The South Asian country of more than 160 million in November signed a deal with the Serum Institute of India to buy 30 million doses of the vaccine developed by British drugmaker AstraZeneca.

The vaccine will arrive in the country by Jan. 25, Abul Bashar Mohammed Khurshid Alam, head of the Directorate General of Health Services, told a news conference.

"The vaccine will be first applied on the health workers and it will be monitored for the next seven days. After that, we'll begin the vaccination across the country in the first week of February," he said.

Frontline workers like health service providers and police will be given priority, health ministry officials said.

Bangladesh, with patchy healthcare facilities, has 523,302 confirmed cases, including 7,803 deaths.

In the global race to develop vaccines against COVID-19, AstraZeneca's candidate is viewed as offering one of the best hopes for many developing countries because of its cheaper price and ability to be transported at normal fridge temperatures.

The Serum Institute, the world's largest manufacturer of vaccines by volume, has partnered with AstraZeneca, the Gates Foundation and the Gavi vaccine alliance to produce more than a billion doses of a COVID-19 vaccine for global supply.

Bangladesh will also get 68 million doses of vaccine from the GAVI vaccine alliance, Health Secretary Abdul Mannan said last month, referring to the global health partnership set up in 2000 to increase access to immunisation in poor countries.

Comments

Comments are closed.